More Time For Formula Claim Guidance Comment: Health And Wellness Industry News Roundup
This article was originally published in The Rose Sheet
Executive Summary
Mannatech founder Robbins leaves board; Nutra recalls GNC Women's supplement; historic UK center licenses Agragen omega-3 technology; and AngioSoma gains nutraceutical formulation patents
You may also be interested in...
Formula Claims Draft Guidance: Health And Wellness Industry News Roundup
FTC considers Vemma settlement; UK firm's green tea claim fails; Axxess has new CEO; NeutraSci reaches Austria, Germany; and more news in brief.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.